…eiving treatment, with over 358 thousand consultations taking place in the latest month. The number of pathways waiting more than two years decreased for the fourth consecutive month, falling by 14% since the peak in March. July also saw just over 87,000 patient pathways closed, a significant increase from the early stages of the pandemic and 10% higher than for the same month in 2021. Performance against targets for diagnostic and therapies servi…
…erformance data published today. A Welsh Government spokesperson said: The latest data shows pressure on our health and care system continues to grow. But our hardworking health and social care staff continue to deliver high quality care when people need it. It is encouraging the number of patients newly diagnosed with cancer starting their first definitive treatment and the number of patients informed they did not have cancer have both increased…
…e hospitals are the highest on record, having increased 11 per cent in the latest year. Attendances at Emergency Departments were the highest for any January on record. Despite this, performance increased against the four-hour target, while the average time spent in emergency departments decreased in January compared to the previous month. The number of patients to receive a ‘red’ or most urgent ambulance response in eight minutes was the second h…
…spital (“Royal Oldham”). On 17 May, Creo announced that Royal Oldham had become the first NHS hospital to immediately implement CROMA and Speedboat™ Inject across multiple endoscopy rooms, putting in place weekly lists for multiple SSD (Speedboat Submucosal Dissection) cases. The hospital has now treated over 40 patients using the new service, representing the fastest time for any NHS hospital to reach the landmark, with exceptional results for pa…
…Home nurse appointments remain available, costing £55 per appointment. The latest of Forth’s achievements is the ISO13485 accreditation. This certification demonstrates Forth’s quality in the delivery of their service and its commitment to safety as the accreditation is only awarded to businesses that provide consistent design, development, production, installation, delivery, and disposal of medical devices that are safe for the intended purpose….
…or the antiviral medicine molnupiravir. They will also now be offered the new combination treatment nirmatrelvir/ritonavir (Paxlovid) which unlike the monoclonal antibody treatment sotrovimab which is given in hospitals can be taken at home. Clinical trials show when Paxlovid is taken within five days of COVID symptoms developing it reduced the risk of hospitalisation from COVID-19 by 88 per cent. People who are eligible for treatment with Paxlov…
…s. Improve collaborative working between the health boards, industry and research communities. Raise the profile of NHS Wales and clinical innovation across the UK. Support closer working relationships between industry, NHS and research groups and clinical trials capabilities. Programme Building on the excellent work that has been done around innovation adoption, we will consider the challenges involved in scaling change and adoption of new prod…
…, leaving the Group debt free. Offering proton beam therapy as well as the latest technology in radiotherapy, imaging and chemotherapy, the Rutherford Cancer Centre South Wales was the first Rutherford centre to be operational in April 2018. The Rutherford Cancer Centre South Wales was also the first centre to offer proton beam therapy and the first to treat a patient in the UK in April 2018. Mike Moran, chief executive of Rutherford Health, said:…